Publications

Letter Epublish

PubMed: 42774885 DOI: 10.1002/hem3.70472

Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.

Hemasphere 10(9):e70472

Authors: Roch Houot, Jean Lemoine, Alexis Claudel, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques-Olivier Bay, Jules Coville, Francisco Llamas-Gutierrez, Karin Tarte, Cédric Portugues, Emmanuel Itti, Xavier Palard-Novello, Paul Blanc-Durand, Yassine Al Tabaa, Clément Bailly, Camille Laurent, François Lemonnier

Affiliations

  • Univ Rennes, CHU Rennes, Service d'hématologie clinique et thérapie cellulaire, INSERM - UMR 1236, Établissement Français du Sang Rennes France.
  • Department of Hematology AP-HP Université Paris Cité Paris France.
  • Department of Hematology UPEC University, Henri Mondor Hospital Créteil France.
  • Department of Hematology Lyon Sud Hospital Center, INSERM U1111 Lyon France.
  • Department of Hematology Montpellier University Hospital, UMR-CNRS 5535 Montpellier France.
  • Department of Clinical Hematology and Cellular Therapy Bordeaux University Hospital Bordeaux France.
  • ULR 7365 - GRITA, Lille University Hospital Lille France.
  • Department of Hematology Toulouse University Hospital, IUCT-Oncopole Toulouse France.
  • Department of Hematology Nantes University Hospital Nantes France.
  • Department of Hematology Nancy University Hospital, INSERM 1256 Université de Lorraine Vandoeuvre-lès-Nancy France.
  • Department of Clinical Hematology and Cellular Therapy Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMR938 Paris France.
  • Department of Hematology and Oncology Saint-Louis Hospital, AP-HP Paris France.
  • Department of Hematology Amiens University Hospital Amiens France.
  • Department of Clinical Hematology Henri Becquerel Center, INSERM U1245 Rouen France.
  • Department of Hematology University Hospital Pitié Salpêtrière, AP-HP Sorbonne University Paris France.
  • Department of Clinical Hematology Dijon University Hospital, INSERM UMR1231 Dijon France.
  • Department of Hematology Institut Paoli-Calmettes Marseille France.
  • Department of Clinical Hematology Necker-Enfants Malades University Hospital, AP-HP, INSERM UMR1163 Paris France.
  • Department of Clinical Hematology and Cellular Therapy Clermont-Ferrand University Hospital Clermont-Ferrand France.
  • Department of Hematology Rennes University Hospital University of Rennes Rennes France.
  • Department of Pathology Rennes University Hospital Rennes France.
  • French Blood Establishment and SITI Laboratory UMR U1236, INSERM, University of Rennes, Rennes University Hospital Rennes France.
  • Department of Biostatistics LYSARC, Lyon-Sud Hospital Pierre-Bénite France.
  • Department of Nuclear Medicine Henri Mondor Hospital Créteil France.
  • Department of Nuclear Medicine University of Rennes, CLCC Eugène Marquis, INSERM Rennes France.
  • Department of Nuclear Medicine CHU H. Mondor, U-PEC, AP-HP Créteil France.
  • Scintidoc Nuclear Medicine Center, Clinique Clémentville Montpellier France.
  • Nantes-Angers Cancer Research Center CRCI2NA, University of Nantes, INSERM UMR1307, CNRS-ERL6075 Nantes France.
  • Department of Pathology Cancer University Institute of Toulouse Oncopole, CHU Toulouse, CRCT INSERM U1037 Toulouse France.
  • Lymphoid Hematology Department Henri Mondor Hospital, Mondor Institute for Biomedical Research, INSERM U955 University Paris-Est Créteil France.

MeSH

Cells, Lymphoma, B-Cell, Lymphoma, B-Lymphocytes, Transplantation